Phew…..that was exhausting!!! I know that is a usual comment after an inspection but this was a two day (and two inspectors, a lead inspector plus a trainee) under the new Licence Based Inspection process.
If you have been keeping an eye on the news lately Donanemab will not be a new name to you. Donanemab is the latest break through drug for the treatment of Alzheimer’s.
On May 25 this year, the NHS terms of service were amended, allowing 100-hour pharmacies to reduce their opening hours from 100 to 72 hours.
Does this mean that Scottish pharmacies have hit the jackpot!?! Well, of course not, this is to ‘ease pressures’ currently faced by pharmacies, and numbers can be very misleading.
After Brexit the MHRA had been preparing to take over the role of sole approver of newly licensed medicines in the UK until now.
The government has just announced that it will be funding a pharmacy common ailment scheme in England as part of a huge £645 million investment for the pharmacy industry over the course of the next two years.
